Skip to main content

INSMED Inc

INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001104506

In the last 90 days, INSMED Inc insiders filed 0 open-market purchases and 2 sales; 672 institutions reported holding it in 13F filings for Q2 2026, worth $23.9B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Key figures

Market capClose on Nov 16, 2026
$27.0B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $3.74M in total
2
13F holdersQ2 2026, −4 vs. previous quarter
672
13F valueReported value at the end of Q2 2026
$23.9B
Superinvestors holdingAt the end of Q2 2026
2

Price chart

From SEC filings, in USD.

Revenue, FY2025
$606.4M
+66.7% year over year
Net income, FY2025
-$1.28B
No comparable prior period
Free cash flow, FY2025
-$967.6M
No comparable prior period
Revenue, Q3 FY2026
$524.4M
+268.4% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $1.28B (210.5% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
14.1M
Shares sold short
Change
+602.8K
+4.5% vs. previous
Days to cover
3.56
At average daily volume

Superinvestors holding INSM, Q2 2026

Go to the superinvestors tab

2 superinvestors report holding INSMED Inc on Form 13F. Percentages are the stock's share of each portfolio.

Maverick Capital

Lee Ainslie

2.1%

INSMED Inc's share of the portfolio

Shares
2,150,762
Value
$229.3M

Duquesne Family Office

Stanley Druckenmiller

3.5%

INSMED Inc's share of the portfolio

Shares
1,424,690
Value
$151.9M

Latest insider trades

See all insider trades

Open-market purchases and sales by INSMED Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2026 (view filing)4:04 PM ETSep 92 daysBrennan David RDirectorSSale−25.0K$124.00−$3.10M−38.9%39.2K after
Aug 19, 2026 (view filing)4:10 PM ETAug 172 daysSharoky Melvin MDDirectorSSale−5.00K$127.53−$637.6K−100.0%0 after
Aug 12, 2026 (view filing)5:04 PM ETAug 102 daysAdsett RogerChief Operating OfficerSSale−239.8K$133.27−$32.0M−70.8%98.7K after
Aug 7, 2026 (view filing)4:39 PM ETAug 61 dayFlammer Martina M.D.Chief Medical OfficerSSale−27.2K$128.61−$3.49M−31.0%60.5K after2 lots10b5-1
Jul 24, 2026 (view filing)5:02 PM ETJul 231 dayLewis WilliamChair and CEOSSale−10.7K$106.06−$1.13M−4.0%259.1K after2 lots10b5-1
Jul 10, 2026 (view filing)4:02 PM ETJul 91 dayLewis WilliamChair and CEOSSale−10.7K$117.40−$1.26M−4.0%259.1K after3 lots10b5-1
Jul 8, 2026 (view filing)4:03 PM ETJul 62 daysFlammer Martina M.D.Chief Medical OfficerSSale−12.3K$109.98−$1.35M−16.9%60.5K after2 lots10b5-1
Jun 26, 2026 (view filing)Jun 251 dayLewis WilliamChair and CEOSSale−21.4K$103.32−$2.21M−7.6%258.9K after5 lots10b5-1
Jun 24, 2026 (view filing)Jun 222 daysSmith Michael AlexanderChief Legal OfficerSSale−1.81K$95.82−$173.1K−4.6%37.6K after10b5-1
Jun 10, 2026 (view filing)Jun 82 daysLewis WilliamChair and CEOSSale−6.51K$94.03−$612.6K−2.5%258.9K after10b5-1

Top 10 13F holders, Q2 2026

See all 672 holders

The largest institutional positions in INSMED Inc at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding INSM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC16,143,583$1.72B0.07%+2,983,416+22.7%Added
BlackRock, Inc.15,807,984$1.69B0.03%−870,162−5.2%Reduced
Vanguard Portfolio Management LLC10,407,962$1.11B0.05%+36,160+0.3%Added
JPMorgan Chase & Co10,428,170$1.09B0.06%−13,722,329−56.8%Reduced
Vanguard Capital Management LLC9,790,865$1.04B0.02%+148,734+1.5%Added
Baker Bros. Advisors LP8,796,111$937.8M4.70%+1,375,000+18.5%Added
Capital International Investors8,238,124$878.3M0.18%+2,642,930+47.2%Added
Darwin Global Management, Ltd.6,431,163$673.6M17.91%−10,374,021−61.7%Reduced
Ameriprise Financial Inc6,179,571$658.9M0.13%+3,121,853+102.1%Added
Orbis Allan Gray Ltd6,076,487$647.9M2.23%+4,203,663+224.5%Added

Holders of 5% or more of INSM

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of INSMED Inc.

Largest holders of INSM from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A7.40%16.1M shares+1.30 ppfrom 6.10%Feb 8, 20215 filingsAug 6, 2026SEC
BlackRock, Inc.13G/A6.60%14.1M shares+1.50 ppfrom 5.10%Jul 17, 20252 filingsJan 21, 2026SEC
Vanguard Capital Management LLC13G5.34%11.5M sharesNewApr 30, 20261 filingApr 30, 2026SEC

2 members of Congress reported 10 trades in INSMED Inc since 2020. Newest filings:

  1. Josh Gottheimer

    House · NJ · Jul 7, 2026

    Sell (partial)$1K-$15K

  2. Gilbert Ray Cisneros, Jr.

    House · CA · Nov 18, 2025

    Sell$1K-$15K

  3. Gilbert Ray Cisneros, Jr.

    House · CA · Oct 10, 2025

    Sell (partial)$1K-$15K

  4. Gilbert Ray Cisneros, Jr.

    House · CA · Sep 12, 2025

    Sell (partial)$1K-$15K

  5. Gilbert Ray Cisneros, Jr.

    House · CA · Aug 14, 2025

    Sell (partial)$1K-$15K